Cooley advised the underwriters on CytoSorbents’ $11.5 million shelf takedown of 2,555,555 shares of common stock. Cowen and Company acted as the sole book-running manager for…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
